ctrl K

Watchlist Price Alert

Lantern Pharma Inc. (LTRN)

NASDAQ: LTRN · Real-Time Price · USD

4.13

0.02 (0.49%)

At close: May 14, 2025, 3:59 PM

Lantern Pharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	174.84K	154.68K	97.42K	3.39K	1.63K	-2.54K
Gross Profit	n/a	-174.84K	-154.68K	-97.42K	-3.39K	-1.63K	2.54K
Operating Income	-22.22B	-17.88M	-14.43M	-12.59M	-5.91M	-2.43M	-1.73M
Interest Income	742.36K	765.39K	204.35K	67.93K	n/a	n/a	n/a
Pretax Income	-20.78B	-15.96M	-14.26M	-12.36M	-5.91M	-2.43M	-1.73M
Net Income	-20.78B	-15.96M	-14.09M	-12.3M	-5.91M	-2.43M	-1.73M
Selling & General & Admin	6.09B	5.98M	5.83M	5.02M	3.66M	1.48M	1.15M
Research & Development	16.13B	11.89M	8.6M	7.57M	2.24M	953.18K	572.1K
Other Expenses	n/a	n/a	-31.55K	160.55K	n/a	n/a	n/a
Operating Expenses	22.03M	17.88M	14.43M	12.59M	5.91M	2.43M	1.73M
Interest Expense	n/a	n/a	204.35K	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	17.88M	14.43M	12.59M	5.91M	2.43M	1.73M
Income Tax Expense	n/a	n/a	-172.81K	-67.93K	-202.91K	-5	2.54K
Shares Outstanding (Basic)	10.76M	10.84M	10.85M	10.9M	6.22M	6.27M	6.22M
Shares Outstanding (Diluted)	10.76M	10.84M	10.85M	10.9M	6.22M	6.27M	6.22M
EPS (Basic)	-1.93K	-1.47	-1.3	-1.13	-0.95	-0.39	-0.28
EPS (Diluted)	-1.93K	-1.47	-1.3	-1.13	-0.95	-0.39	-0.28
EBITDA	-20.59M	-15.79M	-14.42M	-12.27M	-5.9M	-2.43M	-1.73M
EBIT	n/a	-15.96M	-14.43M	-12.36M	-5.91M	-2.43M	-1.73M
Depreciation & Amortization	n/a	174.84K	154.68K	97.42K	3.39K	1.63K	-2.54K